The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2021 | Moving towards a cure for myeloma
Aurore Perrot, MD, of Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France, explains the progress made in the treatment for myeloma and talks on how the rate at which drugs are being developed, advances in measurable residual disease (MRD), and improved risk-adapted strategies, may enable patients with myeloma to be cured in the future. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.
